ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
- Conditions
- Non-Hodgkin's LymphomaMycosis Fungoides
- Registration Number
- NCT02848274
- Lead Sponsor
- Stanford University
- Brief Summary
The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2000
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival (OS) date of diagnosis to death from any cause, up to two years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (13)
Hackensack University Medical Center
๐บ๐ธHackensack, New Jersey, United States
City of Hope
๐บ๐ธDuarte, California, United States
University of Iowa
๐บ๐ธIowa City, Iowa, United States
Stanford University, School of Medicine
๐บ๐ธPalo Alto, California, United States
University of Pittsburg
๐บ๐ธPittsburgh, Pennsylvania, United States
Hospital Italiano de Buenos Aires
๐ฆ๐ทBuenos Aires, Argentina
University of Texas Southwestern
๐บ๐ธDallas, Texas, United States
Peter MacCallum Cancer Center,
๐ฆ๐บMelbourne, Australia
University of Sao Paulo Medical School
๐ง๐ทSao Paulo, Brazil
Peking University First Hospital
๐จ๐ณBeijing, China
The University of Tokyo
๐ฏ๐ตTokyo, Japan
University Hospitals Birmingham
๐ฌ๐งBirmingham, United Kingdom
University of Utah Hospital
๐บ๐ธSalt Lake City, Utah, United States